• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.34 Down 0.04(1.68%) Jan 30, 4:00PM EST
    |After Hours : 2.34 0.00 (0.00%) Jan 30, 4:50PM EST
    Add to Portfolio
    Prev Close:2.38
    Open:2.35
    Bid:2.20 x 500
    Ask:N/A
    1y Target Est:5.30
    Beta:2.09
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.30 - 2.38
    52wk Range:1.82 - 4.96
    Volume:685,829
    Avg Vol (3m):1,023,990
    Market Cap:308.14M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATRS

    Comparison

    Symbol% ChgMkt Cap
    ATRSDown 1.68%308.14M
    BDXDown 1.59%26.51B
    BJCT 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback